Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ignyta Inc (NASDAQ:RXDX)

9.00
Delayed Data
As of Aug 18
 -0.65 / -6.74%
Today’s Change
4.15
Today|||52-Week Range
11.45
+69.81%
Year-to-Date
No recent news for Ignyta Inc.

Today’s Trading

Previous close9.65
Today’s open9.55
Day’s range8.85 - 9.55
Volume707,126
Average volume (3 months)825,721
Market cap$542.9M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+21.80%
Earnings growth (this year)+4.37%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.24

Competitors

 Today’s
change
Today’s
% change
IMGNImmunoGen Inc-0.06-0.99%
MCRBSeres Therapeutics I...-0.39-2.93%
ANIPANI Pharmaceuticals ...+0.40+0.87%
SYRSSyros Pharmaceutical...-0.03-0.15%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$0.00
Annual profit (last year)-$103.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jonathan E. Lim
Chief Operating Officer
Zachary Hornby
Corporate headquarters
San Diego, California

Forecasts